Johnson & Johnson Archives

Healthcare Industry News Weekly Wrap-Up: December 8, 2023

// Biotech and Pharma Therapeutics EyePoint sees stock surge on AMD drug trial data December 4, 2023 / Eyepoint / Drug Trial Data / Mid-stage Study / Eye Disease EyePoint’s medicine, called vorolanib, matched the performance of Regeneron’s top-selling drug...

December 8, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 27, 2023

// Biotech and Pharma Therapeutics Why the evolution of patient advocacy organizations means better data for your rare disease trial October 23, 2023 / Drug Development / Patients / Clinical Trials As a Therapeutic Strategy Lead for Rare Disease at Worldwide...

October 27, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 13, 2023

// Biotech and Pharma Therapeutics Bayer opens California plant to make cell therapies October 10, 2023 / Bayer / California / Cell Therapies / Parkinson’s The new facility is the latest investment from Bayer into cell and gene therapy. Bayer has...

October 13, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 6, 2023

// Biotech and Pharma Therapeutics Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar October 4, 2023 / Boehringer Ingelheim / Humira / AbbVie / Biosimilars After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched...

October 6, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 29, 2023

// Biotech and Pharma Therapeutics J&J shines light on key role in multiple myeloma care team, vowing to raise awareness and offer support September 26, 2023 / Johnson & Johnson / Multiple Myeloma Johnson & Johnson’s multiple myeloma team wants...

September 29, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 8, 2023

// Biotech and Pharma Therapeutics Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream September 20, 2023 / Roche / PeptiDream / Cancer / Bristol Myers Interest in radiopharmaceuticals has been taking off ever since Novartis won drug approval of...

September 8, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 1, 2023

// Biotech and Pharma Therapeutics BMS publishes ‘modest’ multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, 2023 / Bristol Myers Squibb / Multiple Myeloma / Clinical Trial Data Bristol Myers Squibb has reported full phase 1 data...

September 1, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 25, 2023

// Biotech and Pharma Therapeutics Pfizer drops sickle cell disease collab with Syros inherited from GBT takeover July 24, 2023 / Pfizer / Syros Pharmaceuticals / Sickle Cell Disease / Beta Thalassemia At tail-end of 2019, GBT agreed to pay...

August 25, 2023